Re: [新聞] TRXC 通過 FDA 了

※ 引述《Severine (賽非茵)》之銘言： : 原文標題： 這隻我不但有繼續留著 都沒賣 3.7 我又加倉的原始倉位的30% 等於是我現在有N萬股 成本在1.7 牛排加大在加大 全熟牛排加番茄醬最好吃 聽說前幾天有人對我的to the moon 有意見 什麼古板壞人多 剛好那篇文章一發就是最低點 我有在裡面推文說買進訊號來了 有上車的朋友恭喜了 今年牛排加大在加大 那些平常只做台股的 不要隨便做美股啦 你們英文不好閱讀速度又慢 上上下下的你們根本看不懂 先去地球村補美語再來跟我做美股啦 : Asensus Surgical (TRXC) Announces FDA Clearance in General Surgery : 原文連結：https://bit.ly/3q9VDlV : 發布時間：March 3, 2021 6:55 AM EST : 原文內容： : Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , : a medical device company that is digitizing the interface between the surgeon : and patient to pioneer a new era of Performance-Guided Surgery™, today : announced the Company has received an additional FDA clearance for the : Senhance Surgical System which allows for indication expansion in general : surgery in the United States. : Asensus Surgical's technology platform, Senhance® Surgical System, is the : first of its kind digital laparoscopic platform that leverages augmented : intelligence to provide unmatched performance and patient outcomes through : machine learning. Senhance goes beyond the typical surgical robotic systems, : providing surgical assurance through haptic feedback, eye-tracking camera : control, and 3D visualization, and is the first platform to offer 3 mm : instruments (the smallest instrument available in the world on a robotic : surgical platform). : “The expansion into general surgery for the Senhance Surgical System is a : major milestone for the growth and clinical applicability of our technology,” : said Anthony Fernando, Asensus Surgical President and CEO. “General surgery : is, by far, the largest area of manual laparoscopy which can benefit from the : precision and insight of Performance-Guided Surgery. The indication expansion : allows Senhance to be used in many high-value, complex reconstructive : surgeries such as those used to treat reflux and obesity. Including previous : indications granted, the Senhance Surgical System can now be utilized in over : 2.7 million general surgical procedures performed in the US annually." : “Many of the procedures we perform in general surgery require complex : reconstruction throughout a wide surgical field,” said Dr. Sabino Zani, : Assistant Professor of Surgery at Duke University and an investigator in the : clinical studies submitted for indication expansion. “Senhance can now be : seen as a widely applicable tool for general surgeons across the broad range : of procedures that may be performed from deep in the pelvis to the upper : abdomen.” : Senhance US Indication for Use : The Senhance Surgical System is intended to assist in the accurate control of : laparoscopic instruments for visualization and endoscopic manipulation of : tissue including grasping, cutting, blunt and sharp dissection, : approximation, ligation, electrocautery, suturing, mobilization, and : retraction. The Senhance Surgical System is intended for use in general : laparoscopic surgical procedures and laparoscopic gynecological surgery. The : system is indicated for adult use. It is intended for use by trained : physicians in an operating room environment in accordance with the : instructions for use. : 心得/評論： ※必需填寫滿20字 : 前陣子的飆股,雖然二月有滿滿的預期會通過FDA 但大漲大跌之下還是賣了一點 : 部位.這陣子的回調原本希望回到3.5再加倉,這下看來沒機會了.. : ----------------------------------發文提醒------------------------------- : 1.發文前請先詳閱[新聞]分類發文規範，未依規範發文將受處份。 : 2.連結過長請善用 https://bit.ly/ 縮網址，連結能不能點擊者板規1-2-2處份。 : 3.心得/評論請盡量充實，*[m心得過短或濫竽充數將會以1-2-3&一行文規範水桶處份 : 4.發文請依照格式文章標明段落，不符合格式者依4-1刪文處分。 : ------------------ 以上注意事項請勿刪除 違者4-1 刪文處分----------------- ----- Sent from JPTT on my iPhone -- ※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 114.136.230.246 (臺灣) ※ 文章網址: https://www.ptt.cc/bbs/Stock/M.1614778054.A.FAA.html